NCT04087018 2024-09-19Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid TumorsArcus Biosciences, Inc.Phase 1 Completed18 enrolled
NCT03713905 2023-04-10Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid TumorsGuangzhou Gloria Biosciences Co., Ltd.Phase 1 Completed293 enrolled